MedPath

Effect of Human Milk Fortification Beyond Hospital Discharge on the Growth of Premature Infants

Phase 2
Conditions
Health Condition 1: P051- Newborn small for gestational ageHealth Condition 2: P071- Other low birth weight newbornHealth Condition 3: P073- Preterm [premature] newborn [other]
Registration Number
CTRI/2022/08/044831
Lead Sponsor
Shrutiprajna Kar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All preterm babies between 26 to 32 weeks gestation or birthweight less than 1500 grams with multi-nutrient milk fortification started during hospital stay

Exclusion Criteria

1. Neonates with major gastro-intestinal congenital malformations

2. Syndromic neonates assessed antenatally or postnatally

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the rate of weight gain (grams/kg/day) at 40 weeks P.M.A. in preterm (26-32 weeks gestation) or VLBW neonates (1500 grams) being continued on fortified breast milk beyond discharge with those who received unfortified breast milkTimepoint: Baseline and 40 weeks postmenstrual age
Secondary Outcome Measures
NameTimeMethod
To calculate cZ scores (change in Z score of weight, length & height from birth) at term equivalent according to modified Fentons growth charts <br/ ><br>Timepoint: Term equivalent age;To compare the rate of increase in head circumference (cm/week) from birth till term equivalent age <br/ ><br>Timepoint: Term equivalent age;To compare the rate of increase in length (cm/week) from birth till term equivalent age <br/ ><br>Timepoint: Term equivalent age;To estimate the percentage of Extrauterine growth restriction at 40 weeks P.M.A. <br/ ><br>Timepoint: Term equivalent age
© Copyright 2025. All Rights Reserved by MedPath